“Treat Addiction. Save Lives.”

Welcome To Our Website!

Our mission is to improve the care and treatment of people with the disease of addiction and advance the practice of Addiction Medicine.

Treatment decisions on the use of FDA-approved medications for addiction should be made only by skilled physicians.

ABMS RECOGNIZES ABAM AS THE NEWEST MEDICAL SUBSPECIALTY!!!!!

Drs. Sokol and O’Connor said it eloquently in their letter of this announcement to all ABAM diplomates:

As we all celebrate this occasion, we hope that you will take a moment and reflect with pride on your own contributions to our newly recognized field. As ABAM diplomates you have been at the forefront in the care of patients with substance use disorders. Your work has been driven by the will to care for patients and families, and to improve their lives and the health of your community. You have stood up to stigma, ignorance and to outdated policies and practices that accompanied this most challenging of all diseases. You have had many successes with patients and colleagues along the way and have set the stage for medicine’s response to addiction. You have pioneered this new era in American medicine and healthcare. Thank you, and savor the moment.

 

Happy New Year!!!!

We will be having our annual meeting at the ASAM national conference in April on Friday April 15th between 4-5 pm.  I hope all will participate if you’re going to attend the conference.  An agenda will go out which will outline various topics we will be discussing.  Please feel free to suggest additions to the agenda if you wish to discuss specific topics.

The opioid epidemic continues to be at the forefront of issues facing Tennesseans as well as nationally.  We will continue to advocate for treatment, the most important aspect for change.  This includes increasing medication assisted therapy.  Currently there continues to be various legislative and regulatory proposals which will shape how we practice as addiction specialists.  Please do your part by contacting your local representatives at both the state and national level. The most effective role is to help educate our legislators on standards of care and effectiveness of treatment.  Another important aspect is to convey that treatment and prevention saves money in the long run and there is research to prove it.

Additionally, neonatal abstinence continues to be a hot topic in our state.  We must do our part and educate our fellow physicians, including obstetricians and pediatricians, of the benefits of working together for positive outcomes.  Recently many high risk obstetricians and neonatal intensivists have expressed an interest in developing multi-disciplinary teams. In Chattanooga, the high risk obstetrical group has asked to form a team which will help to improve outcomes.  If there is a need in your community, I urge you to do the same in assisting the opiate dependent mothers.

I also want to inform you of a study which has begun which will be looking at neonatal abstinence syndrome and the variability in symptom severity.  Genetic testing will be carried out to assess whether certain genotypes are more at risk than others.  Our esteemed colleague, Dr. John Standridge, is the principle investigator. Feel free to contact him with your interest in participating in this research project.  Participation is encouraged. Dr. Standridge will be presenting his research to the International Conference on Opioids in June, 2016, at Harvard Medical School in Boston.

Lastly, I have been informed that TnSAM will be joining with the North Carolina Chapter at the April North Carolina Conference (April 22-24th) in Asheville, N.C. in a collaborative effort. More to follow.

Thank you for all you do…..

Dr. Zotos

ANNOUNCEMENT OF ANNUAL MEETING — APRIL 15, 2016 at 4:00 p.m., BALTIMORE, MD

As required by our bylaws, “there shall be an Annual Meeting of the Society. The time and place of such Annual Meeting shall be determined by the Board of Directors, and will by tradition coincide with the annual Med-Sci Meeting of ASAM. Written notice thereof shall be given to all members, by mail or e-mail to the address of the record with the Society or other address supplied by the member for that purpose. All notices shall be sent not less than thirty (30) day prior to each meeting. Additional notices shall be posted on the official Society website…”

AGENDA ITEMS WILL INCLUDE ELECTION OF OFFICERS AND BOARD MEMBERS.

The Annual Meeting shall be chaired by the President of the Society, Dr. Alex Zotos, and shall be for the purpose of disseminating information to the membership and conducting any other necessary business. Officers shall be recognized and introduced to the membership along with incoming directors at the beginning of each Annual Business Meeting.

Read and Recommended (New Feature):

Read Senator Edward J. Markey’s bill to remove limits from the numbers of patients a provider (physician/ANP/PA) can treat with buprenorphine.

The Development and Maintenance of Drug Addiction (Neuropsychopharmacology)

Read Governor Shumlin’s 2014 State of the State Address, dedicated to heroin and other opiate addiction in Vermont.

Read the letter to the editor of the New York Times. titled Treatment of Addiction, by Thomas Farley, departing Commissioner of Health in New York City.

The TnSAM Constitution and Bylaws were ratified by TnSAM members on November 22, 2013.

One of the great minds and original thinkers in TnSAM is a former Tennessee president, Rich Soper, T.M.I.A.H.N.T.L.H. (Too many initials after his name to list here).  Rich has a special column, listed below as Soper’s Soapbox.  In this section his free flow of random thoughts (which he calls “Liquid Soap”) is published as we receive them. These also fall in the read and recommended categories.  Please avail yourself of his insights and wisdom. In an article titled “Legislating Limited Treatment Will Worsen Outcomes”, he discusses — BRILLIANTLY — the unintended consequence of learned helplessness that derives from legislated mandates of inadequate, thus failed, treatments. In another he is the scholar, describing process addiction.  Tennessee may not be the biggest or richest chapter, but we have the beauty.  Avail yourself.

Items of Interest for TNSAM Members

TNSAM’s Agenda (PEACE):

  1. Parity – equality in access, benefits, coverage, respect, and treatment
  2. Education – of public, legislators, physicians in training and those in practice
  3. Advocacy – advancing the stature and recognition of the specialty
  4. Communication – facilitating the spread of ideas among members and the public
  5. Evidence-based practice – improve the quality of addiction treatment through research and education

ASAM Issues Policy Statement on Patient Access to Addiction Medications

Read the full report

News on Parity — On November 8, 2013, the Departments of Treasury, Labor, and Health and Human Services (collectively, the “Departments”) jointly issued final regulations under the Mental Health Parity and Addiction Equity Act of 2008 (the “MHPAEA”). In general, the MHPAEA requires that group health plans offering mental health/substance use disorder benefits that apply any financial requirements or treatment limitations to these benefits cannot apply requirements or limitations that are more restrictive than the requirements or limitations applied to medical/surgical benefits.

Effective Date

The final regulations apply to group health plans for plan years beginning on or after July 1, 2014 (i.e., January 1, 2015 for calendar year plans). Until that time, plans and issuers must continue to comply with the interim final regulations, which were effective for plan years beginning on or after July 1, 2010.

Background

The MHPAEA requires parity between mental health/substance use disorder benefits and medical/surgical benefits with respect to financial requirements and treatment limitations. Plans providing mental health/substance use disorder benefits generally may impose financial requirements (such as deductibles, copayments, coinsurance and out-of-pocket limitations) or quantitative treatment limitations (such as frequency of treatment, number of visits, days of coverage or other similar limits on the scope or duration of treatment) on mental health/substance use disorder benefits, as long as the requirements or limitations are on par with those imposed on medical/surgical benefits. Specifically, the requirements or limitations can be no more restrictive than the “predominantfinancial requirements or treatment limitations applied to “substantially all” medical/surgical benefits.

As previously announced in the interim final regulations, the “predominant/substantially all” test applies on a classification-by-classification basis, based on six classifications of benefits: (i) inpatient, in-network; (ii) inpatient, out-of-network; (iii) outpatient, in-network; (iv) outpatient, out-of-network; (v) emergency care; and (vi) prescription drugs. The final regulations provide that office visits can be split out as a subclassification separate from outpatient services. The final regulations specifically prohibit subclassifications for generalists and specialists.

See the News from Maryland’s new parity initiatives.

Editorials

  • 2013-08-03 – New Feature! Editorials may be found here. Editorials may be provided by any member of TnSAM. Please submit by email to the president of TnSAM. Submissions that are overly long or inflammatory may be returned for re-writing.

Old News

The 2013 TnSAM Addiction Medicine Conference held in Chattanooga, TN, August 29th and 30th, 2013, was highly successful. One hundred-thirty people from many different professions registered.  The ER/LA Opioid REMS: Achieving Safe Use While Improving Patient Care session addressed our most pressing health problem of prescription drug abuse. Ninety-one people attended this session, the vast majority being prescribers for whom the course was intended. Thank you to all who attended this important conference, and thanks for all you do!

Only those who regard healing as the ultimate goal of their efforts can, therefore, be designated as physicians.— Rudolf Virchow